Laiteerapong N, Alexander J, Philipson L, Winn AN, et al. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists. Ann Intern Med 2023;176:eL230007.
PMID: 37068291